HLS Therapeutics Inc Financial Overview
HLS Therapeutics Inc's market cap is currently C$153.55M. The company's EPS TTM is C$-0.16796583599999998; its P/E ratio is -7.84; HLS Therapeutics Inc is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.04. See an overview of income statement, balance sheet, and cash flow financials.
